Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 25, 2010HaematologicaOpen Access

Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab

View Full Paper
Ask AI
Bookmark
Share

Authors

MVMichael S. van der VeerUtrecht UniversityMWMichel de WeersGenmab (Netherlands)BKBerris van KesselUtrecht University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Veer et al. (2010) studied this question.

synapsesocial.com/papers/6a0cf0067e512f50ffcc8d68https://doi.org/10.3324/haematol.2010.030759
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Advances in biology of multiple myeloma: clinical applications2004 · 584 citations
  2. 2Human CD38, a cell‐surface protein with multiple functions1996 · 309 citations